NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients
批准号:
8887154
负责人:
Chang-Gyu Hahn
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-08 至 2017-05-31
关键词:
AddressAgeAmygdaloid structureAttenuatedAutopsyBehaviorBiochemicalBiologyBrainBrain regionCell NucleusCellsComplexCorpus striatum structureDRD2 geneDendritic SpinesDevelopmentDopamine ReceptorEmotionalEnzymesErbB4 geneEvaluationExcitatory SynapseFeedbackGlutamatesHistologicHyperactive behaviorImmunohistochemistryImmunoprecipitationInhibitory SynapseInstructionIntercalated CellInterneuronsIslandLeadLigandsLinkMedialMediatingMolecularMotivationN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNR1 geneNamesNeurocognitiveNeuronsNucleus AccumbensOutcomeOutputPatientsPerceptionPlayPostsynaptic MembranePrefrontal CortexProtein KinaseProteinsProteomicsReceptor SignalingRewardsRoleSamplingSchizophreniaSignal TransductionSignaling MoleculeStructureSymptomsSynapsesSynaptic MembranesSynaptic VesiclesSynaptic plasticitySynaptophysinTestingThalamic structureThickTissue MicroarrayTyrosine 3-MonooxygenaseTyrosine PhosphorylationVentral StriatumVertebral columnattenuationcell typecholinergicdensityemotional experienceemotional reactionemotional stimulusgamma-Aminobutyric Acidindexinginsightinterestnovelpostsynapticpresynapticreceptorreceptor functionresearch studyresponsesexspinophilintomographytransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Accumulating evidence suggests that negative symptoms of schizophrenia may be mediated by altered circuit activity in the amygdala; specifically the basolateral amygdala (BLA) -nucleus accumbens (NA) and BLA- central nucleus (CeA) connections. Given that circuit activity is governed by synaptic strength/plasticity, NMDA receptor function, a key modulator of synaptic plasticity, may play a pivotal role in the BLA-NA and BLA-CeA circuitry. NMDA receptor function is linked to an array of neurocognitive functions and can induce endophenotypic behaviors of schizophrenia when perturbed in specific brain regions. We postulate that altered synaptic connectivity associated with dysregulated NMDA receptor function in the BLA-NA and BLA- CeA circuitry may lead to negative symptoms of schizophrenia. The BLA circuitry receives robust Dl and D2R mediated input from the prefrontal cortex and striatum and its overall activity is regulated by feedfoward and feedback inhibition via GABAergic neurons in intercalated islands. Cell type specific assessment of dopaminergic and NMDA receptor signaling therefore can reveal the intercellular dynamics leading to faulty circuitry of the amygdala in schizophrenia. To address this, we propose a postmortem study in which we conduct histologic and biochemical assessment of the synaptic strength and signaling activity of NMDA and dopaminergic receptors in a cell type specific manner. In the postmortem amygdala of 30 schizophrenia subjects and their matched controls, we will examine dendritic spine density and the integrity of synapses in principal and interneurons separately. Evaluation of receptor signaling in postmortem brains has been a challenging task. We have recently developed a number of paradigms that permit us to do so and found attenuation in tyrosine phosphorylation of NMDAR2A/2B reduced Src activity and altered protein interactions of NMDA receptor complexes in the PFC of SCZ patients. In this project we will examine the NMDA receptor function using immunoprecipitation -SRM-Mass spec analysis. Dopaminergic signaling can impact on NMDA receptor signaling in principal and interneurons modulating the overall circuit activity. We will examine presynaptic and postsynaptic segments of dopaminergic input using histologic and biochemical assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
-
批准号:10321200
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2019
-
负责人:Chang-Gyu Hahn
-
依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
-
批准号:9926314
-
项目类别:
-
资助金额:$64.8万
-
财政年份:2019
-
负责人:Chang-Gyu Hahn
-
依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
-
批准号:10545764
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2019
-
负责人:Chang-Gyu Hahn
-
依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
-
批准号:10064372
-
项目类别:
-
资助金额:$68.8万
-
财政年份:2019
-
负责人:Chang-Gyu Hahn
-
依托单位:
Acquisition of triple quadrupole mass spectrometer for quantitative proteomics
-
批准号:8447862
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2013
-
负责人:Chang-Gyu Hahn
-
依托单位:
Lithium responsiveness
-
批准号:7845611
-
项目类别:
-
资助金额:$54.6万
-
财政年份:2008
-
负责人:Chang-Gyu Hahn
-
依托单位:
Lithium responsiveness
-
批准号:7620394
-
项目类别:
-
资助金额:$54.39万
-
财政年份:2008
-
负责人:Chang-Gyu Hahn
-
依托单位:
Lithium responsiveness
-
批准号:8037754
-
项目类别:
-
资助金额:$54.03万
-
财政年份:2008
-
负责人:Chang-Gyu Hahn
-
依托单位:
Lithium responsiveness
-
批准号:8228099
-
项目类别:
-
资助金额:$54.02万
-
财政年份:2008
-
负责人:Chang-Gyu Hahn
-
依托单位:
Neuregulin 1-erbB signaling in schizophrenia
-
批准号:7292681
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2006
-
负责人:Chang-Gyu Hahn
-
依托单位:
Neuregulin 1-erbB signaling in schizophrenia
-
批准号:7475703
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2006
-
负责人:Chang-Gyu Hahn
-
依托单位:
Neuregulin 1-erbB signaling in schizophrenia
-
批准号:7143820
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2006
-
负责人:Chang-Gyu Hahn
-
依托单位:
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia
-
批准号:8895741
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2006
-
负责人:Chang-Gyu Hahn
-
依托单位:
Neuregulin 1-erbB signaling in schizophrenia
-
批准号:7656623
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2006
-
负责人:Chang-Gyu Hahn
-
依托单位:
Olfactory neurons from bipolar patients
-
批准号:6652132
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2002
-
负责人:Chang-Gyu Hahn
-
依托单位:
Olfactory neurons from bipolar patients
-
批准号:6951861
-
项目类别:
-
资助金额:$17.66万
-
财政年份:2002
-
负责人:Chang-Gyu Hahn
-
依托单位:
Olfactory neurons from bipolar patients
-
批准号:6788811
-
项目类别:
-
资助金额:$17.66万
-
财政年份:2002
-
负责人:Chang-Gyu Hahn
-
依托单位:
Olfactory neurons from bipolar patients
-
批准号:6477653
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2002
-
负责人:Chang-Gyu Hahn
-
依托单位:
Olfactory neurons from bipolar patients
-
批准号:7113784
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2002
-
负责人:Chang-Gyu Hahn
-
依托单位:
STUDY OF BIPOLAR DISORDER
-
批准号:6392832
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2000
-
负责人:Chang-Gyu Hahn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: